InvestorsHub Logo
Followers 18
Posts 943
Boards Moderated 0
Alias Born 03/23/2011

Re: None

Sunday, 08/03/2014 2:40:57 AM

Sunday, August 03, 2014 2:40:57 AM

Post# of 130507
If OPKO Health to Collaborate with Bristol-Myers Squibb on Blood Test for Alzheimer's Disease, and use Lab Corp, old news yes but to see how its structured. Its very old news in the world of Bio-Tech,
but you can see a structure that AMBS might have soon.

Quote:
"
MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE Amex:OPK) today announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company (NYSE:BMY) relating to OPKO's new diagnostic test technology. OPKO's simple blood tests are being developed, based on its proprietary platform technology, to identify biomarkers for a wide variety of diseases including neurodegenerative disorders and various malignancies. As part of the project, OPKO and Bristol-Myers Squibb will investigate the utility of OPKO's novel technology for diagnosis of Alzheimer's disease and for identifying individuals with early stage cognitive impairment that are likely to progress to Alzheimer's disease. "
End Quote
Ref: http://investor.opko.com/releasedetail.cfm?ReleaseID=542628